Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition comprising FLT3 inhibitor and hypomethylating agent for treating acute myeloid leukemia

Pharmaceutical composition comprising FLT3 inhibitor and hypomethylating agent for treating acute myeloid leukemia

US Patent 12433867 · Granted Oct 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyridine derivative compounds and use of same2025
Imidazopyridine derivative compounds and use of same2025
Imidazopyridine derivative compounds and use of same2025
Imidazopyridine derivative compounds and use of same2025
Control device for a hybrid electric vehicle and a control method thereof2025
Ceramic electronic component having external electrode which includes boron with2025
Fluid treatment module2025
Hybrid electric vehicle and method of driving control for same2025
Pharmaceutical composition for treating acute myeloid leukemia, containing FLT3 2025
Portable water bottle having a UV light sterilization module2025
Anode for secondary battery, method of fabricating the same and lithium secondar2025
Sterilization module2025